DynaCDR: dynamic graph learning for accurate cancer drug response prediction

Background Accurate prediction of cancer drug response is essential for precision oncology, yet existing computational methods, particularly static graph-based models, suffer from two fundamental limitations: information leakage arising from global graph construction that inadvertently mixes training and test instances, and insufficient integration of multi-modal biological data with context-dependent relational reasoning. Results To overcome these challenges, we propose DynaCDR, a multi-modal framework built upon a dynamically constructed batch-local heterogeneous graph strategy. Unlike static global graphs that risk leaking test information through fixed topological connections, DynaCDR constructs local subgraphs exclusively from samples within each training batch, ensuring strict separation between training and test instances while capturing context-dependent drug-cell line interactions. Extensive experiments on the GDSC dataset demonstrate that DynaCDR achieves superior predictive performance ( RMSE = 0.7836, R 2 = 0.8817), outperforming the leakage-free static baseline, indicating that the gains arise from dynamic, context-dependent relational learning rather than from leakage avoidance alone. The model exhibits remarkable robustness in few-shot scenarios (using only 5–20% of training data) and exceptional generalization to unseen cell lines. More importantly, under the stringent cross-dataset transfer (GDSC-to-TCGA, no fine-tuning) that simulates real-world clinical domain shifts, DynaCDR consistently outperformed all other models by a substantial margin, despite an inevitable overall performance decline caused by the intrinsic in vitro versus in vivo gap. Crucially, ablation studies confirm the critical role of the graph attention mechanism, while biological enrichment analyses reveal that sensitive drug targets are significantly enriched in canonical pathways. Conclusions Overall, DynaCDR offers a general paradigm for precision oncology that addresses fundamental limitations of static graph-based approaches.

Authors

Institutions

Publication Details

Journal
BMC Biology
Published
2026-11-21
DOI
https://doi.org/10.1186/s12915-026-02792-4
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

DynaCDR: dynamic graph learning for accurate cancer drug response prediction

Lei Liu, Fan Zhong, Liyan Zeng, Yao Chen
BMC Biology
Computational Drug Discovery Methods
article

DynaCDR: dynamic graph learning for accurate cancer drug response prediction

Lei Liu, Fan Zhong, Liyan Zeng, Yao Chen
article en

Abstract

Background Accurate prediction of cancer drug response is essential for precision oncology, yet existing computational methods, particularly static graph-based models, suffer from two fundamental limitations: information leakage arising from global graph construction that inadvertently mixes training and test instances, and insufficient integration of multi-modal biological data with context-dependent relational reasoning. Results To overcome these challenges, we propose DynaCDR, a multi-modal framework built upon a dynamically constructed batch-local heterogeneous graph strategy. Unlike static global graphs that risk leaking test information through fixed topological connections, DynaCDR constructs local subgraphs exclusively from samples within each training batch, ensuring strict separation between training and test instances while capturing context-dependent drug-cell line interactions. Extensive experiments on the GDSC dataset demonstrate that DynaCDR achieves superior predictive performance ( RMSE = 0.7836, R 2 = 0.8817), outperforming the leakage-free static baseline, indicating that the gains arise from dynamic, context-dependent relational learning rather than from leakage avoidance alone. The model exhibits remarkable robustness in few-shot scenarios (using only 5–20% of training data) and exceptional generalization to unseen cell lines. More importantly, under the stringent cross-dataset transfer (GDSC-to-TCGA, no fine-tuning) that simulates real-world clinical domain shifts, DynaCDR consistently outperformed all other models by a substantial margin, despite an inevitable overall performance decline caused by the intrinsic in vitro versus in vivo gap. Crucially, ablation studies confirm the critical role of the graph attention mechanism, while biological enrichment analyses reveal that sensitive drug targets are significantly enriched in canonical pathways. Conclusions Overall, DynaCDR offers a general paradigm for precision oncology that addresses fundamental limitations of static graph-based approaches.

BMC Biology
Shanghai Medical College of Fudan University (CN), Fudan University (CN)
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon